Skip to main content

Avoiding Common Errors During Viable Microbial Contamination Investigations

  • Chapter
  • First Online:
Book cover Sterile Product Development

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 6))

  • 4169 Accesses

Abstract

Pharmaceutical companies are required by regulatory authorities to conduct thorough investigations into microbial contamination events related to aseptic manufacturing of sterile products. Often a variety of errors are made during the course of such investigations. In many cases, those are errors in judgment which preclude finding the Root Cause of the problem and prevent identification of a long-term solution. The major goals of such an investigation are to locate the source of the contaminating microorganism and then to determine the Root Cause, i.e., how that microbial contaminant got into the “sterile” product or aseptic processing area. Often wrong assumptions are made based upon previous experience or lack of sufficient technical knowledge. Extraordinary Environmental Monitoring (EM) is typically required to locate the source(s) of the microbial contamination. Examples of errors in judgment (Wrong Thinking) and case studies are provided to aid the reader in conducting the best possible sterility assurance failure investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • U.S. Department of Health and Human Services, Food & Drug Administration, September 2004, Guidance for industry: Sterile drug products produced by aseptic processing—current good manufacturing practice. U.S. FDA, Silver Spring

    Google Scholar 

  • USP (2013) Chapter <1116> Microbiological control and monitoring of aseptic processing environments. The United States Pharmacopeial Convention, Rockville, p 707

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenneth H. Muhvich Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Muhvich, K.H. (2013). Avoiding Common Errors During Viable Microbial Contamination Investigations. In: Kolhe, P., Shah, M., Rathore, N. (eds) Sterile Product Development. AAPS Advances in the Pharmaceutical Sciences Series, vol 6. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7978-9_19

Download citation

Publish with us

Policies and ethics